KIM DENNIS D 4
4 · CymaBay Therapeutics, Inc. · Filed Mar 30, 2023
Insider Transaction Report
Form 4
KIM DENNIS D
Chief Medical Officer
Transactions
- Sale
Common Stock
2023-03-28$8.98/sh−100$899→ 20,000 total - Exercise/Conversion
Common Stock
2023-03-28$4.37/sh+100$437→ 20,100 total - Exercise/Conversion
Employee Stock Option (right to buy)
2023-03-28−100→ 289,900 totalExercise: $4.37Exp: 2031-05-16→ Common Stock (100 underlying)
Footnotes (1)
- [F1]The original option grant vested as to 1/4 of the underlying shares on May 17, 2022 and vests as to 1/48 of the underlying shares monthly thereafter.